Binary, LLC
Little Rock, AR, US· latest recorded location
Binary, LLC is named on 0 US grants and 5 published applications in this corpus. Its most frequent classification is C12Q (Measuring or testing processes involving enzymes, nucleic acids or microorganisms).
- Granted patents
- 0
- Published applications
- 5
- Inventors
- 6
- Granted in 2026 so far
- 0
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 3 |
By publication year. 2026 runs to 8 Oct.
Technology areas
Share of 5 documents
- C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms4
- C12YEnzymes4
- G01NInvestigating or analysing materials by determining their chemical or physical properties4
- A01NPreservation of bodies of humans or animals or plants or parts thereof1
- A61LMethods or apparatus for sterilising materials or objects in general1
- C02FTreatment of water, waste water, sewage, or sludge1
Recent patents
No granted patents yet.
- Oxidase-based chemiluminescence assay of phagocytic leukocytes in whole blood and body fluids applicable to point-of-care (poc) diagnostic testing point-of-care (poc) measurement of absolute neutrophil function (anf)27 Aug 2026US 2026/0251635 A1
- Oxidase-based chemiluminescence assay of phagocytic leukocytes in whole blood and body fluids applicable to point-of-care (poc) diagnostic testing point-of-care (poc) measurement of absolute neutrophil function (anf)14 May 2026US 2026/0133184 A1
- Oxidase-based chemiluminescence assay of phagocytic leukocytes in whole blood and body fluids applicable to point-of-care (poc) diagnostic testing point-of-care (poc) measurement of absolute neutrophil function (anf)5 Mar 2026US 2026/0063624 A1
- Oxidase-based chemiluminescence assay of phagocytic leukocytes in whole blood and body fluids applicable to point-of-care (poc) diagnostic testing point-of-care (poc) measurement of absolute neutrophil function (anf)29 Sep 2022US 2022/0308046 A1
- Binary compositions and methods for sterilization15 Nov 2007US 2007/0264355 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.